Narayan C. Chaudhuri

Narayan C. Chaudhuri, PhD, is an accomplished expert in Organic Chemistry with extensive experience in CMC, process chemistry, and cGMP manufacturing. Currently serving as Executive Director at Atea Pharmaceuticals, Inc., since 2020, Narayan leads the technical aspects of CMC chemical process and product development for transformative antiviral therapies targeting HCV, dengue, RSV, SARS, MERS, and COVID-19. Previous roles include CMC Technical Writer at DPS Group Global, Technical Ops Consultant at Tarveda Therapeutics, and Senior Manager at Alexion Pharmaceuticals, with a proven track record in supporting clinical studies, technology transfers, and compliance with regulatory standards across various biotechnology firms. Narayan's educational background includes a PhD in Synthetic Organic Chemistry from the Indian Institute of Technology, Kanpur, and dual post-doctoral associateships in Synthetic Organic and Bio-organic Chemistry, contributing to a robust foundation in the field.